Analyst Price Targets — KVUE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 12:10 pm | — | UBS | $20.00 | $18.91 | TheFly | Kenvue price target raised to $20 from $18 at UBS |
| April 14, 2026 12:53 pm | — | Barclays | $18.00 | $17.39 | TheFly | Kenvue price target lowered to $18 from $19 at Barclays |
| February 18, 2026 12:42 pm | — | UBS | $19.00 | $18.41 | TheFly | Kenvue price target raised to $19 from $17 at UBS |
| February 18, 2026 12:10 pm | — | Canaccord Genuity | $18.00 | $18.41 | TheFly | Kenvue price target raised to $18 from $17 at Canaccord |
| January 30, 2026 2:04 am | — | Jefferies | $18.00 | $17.20 | TheFly | Kenvue downgraded to Hold from Buy at Jefferies |
| October 29, 2025 10:27 am | — | Canaccord Genuity | $15.00 | $14.51 | TheFly | Kenvue downgraded to Hold from Buy at Canaccord |
| October 28, 2025 4:56 pm | Javier Escalante | Evercore ISI | $18.00 | $14.50 | StreetInsider | Evercore ISI Warns on Kenvue Inc (KVUE) Amid 3.5pct Decline: 'It's not just Tylenol' |
| October 27, 2025 9:42 am | — | Jefferies | $23.00 | $15.00 | StreetInsider | Kenvue Inc (KVUE) PT Lowered to $23 at JefferiesMember Login |
| October 24, 2025 11:18 am | — | Deutsche Bank | $18.00 | $15.07 | TheFly | Kenvue price target lowered to $18 from $20 at Deutsche Bank |
| October 8, 2025 12:45 pm | — | UBS | $17.00 | $16.21 | TheFly | Kenvue price target lowered to $17 from $23 at UBS |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for KVUE

A federal appeals court on Monday revived hundreds of private lawsuits against Kenvue and many pharmacies and retailers, alleging that the Tylenol painkiller causes autism and attention deficit hyperactivity order.

Kimberly-Clark is far from flashy, but what it lacks in glitz and glam, it makes up for with predictability.

Dividend Kings are companies that have increased their dividend payments for at least 50 consecutive years. Automatic Data Processing has seen its share price drop over concerns about unemployment.

Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance.

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
